Last Updated: July 10, 2026

Difgen Pharms Company Profile

✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for DIFGEN PHARMS

DIFGEN PHARMS has seven approved drugs.

Summary for Difgen Pharms

US Patents:	0
Tradenames:	14
Ingredients:	7
NDAs:	7

Drugs and US Patents for Difgen Pharms

+ Get email alerts for changes to this table

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Difgen Pharms	BUPRENORPHINE	buprenorphine	FILM, EXTENDED RELEASE;TRANSDERMAL	210272-005	Sep 23, 2021	AB	RX	No	No		⤷ Start Trial				⤷ Start Trial
Difgen Pharms	FENTANYL-100	fentanyl	FILM, EXTENDED RELEASE;TRANSDERMAL	077449-004	Oct 20, 2008	AB	RX	No	No		⤷ Start Trial				⤷ Start Trial
Difgen Pharms	FENTANYL-75	fentanyl	FILM, EXTENDED RELEASE;TRANSDERMAL	077449-003	Oct 20, 2008	AB	RX	No	No		⤷ Start Trial				⤷ Start Trial
Difgen Pharms	LIDOCAINE	lidocaine	PATCH;TOPICAL	217221-001	Mar 25, 2025	AB	RX	No	No		⤷ Start Trial				⤷ Start Trial
Difgen Pharms	BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE	buprenorphine hydrochloride; naloxone hydrochloride	FILM;BUCCAL, SUBLINGUAL	212756-002	Jun 2, 2022	AB	RX	No	No		⤷ Start Trial				⤷ Start Trial
Difgen Pharms	BUPRENORPHINE	buprenorphine	FILM, EXTENDED RELEASE;TRANSDERMAL	210272-003	Sep 23, 2021	AB	RX	No	No		⤷ Start Trial				⤷ Start Trial
Difgen Pharms	CLONIDINE	clonidine	SYSTEM;TRANSDERMAL	076157-003	Aug 18, 2009		DISCN	No	No		⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Difgen Pharms

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.